Low-grade dysplastic nodules (LGDNs) resemble RN morphologically but are clonal
•
High-grade dysplastic nodules (HGDNs): Preneoplastic lesion; likely precursor of hepatocellular carcinoma (HCC)
Macroscopic
•
> 1 cm but usually < 3 cm
Microscopic
•
RN/LGDN: Plates 1-2 cells thick, portal tracts present, no architectural or cytologic atypia
•
HGDN: Plates focally up to 3 cells thick; small cell change with increased nuclear:cytoplasmic ratio
Unpaired arterioles and pseudoacinar architecture can be present
•
Reticulin is preserved
May be focally lost in HGDN
Top Differential Diagnoses
•
Small cell change, high nuclear:cytoplasmic ratio, pseudoacinar architecture, and unpaired arterioles favor HGDN over LGDN
•
Uniformly thick plates (> 3 cells) are most important feature distinguishing HCC from HGDN
Prominent pseudoacinar architecture, numerous unpaired arterioles, and loss or fragmentation of reticulin favor HCC
•
Stromal invasion distinguishes early HCC from HGDN
Lack of CK7(+) ductular reaction is useful in demonstrating stromal invasion
•
Positive results with 2 out of 3 markers (GPC, GS, HSP70) favor HCC
TERMINOLOGY
Abbreviations
•
Regenerative nodule (RN), large regenerative nodule (LRN), low-grade dysplastic nodule (LGDN), high-grade dysplastic nodule (HGDN)
Synonyms
•
Macroregenerative nodule (MRN), adenomatous hyperplasia
•
Borderline nodule, type II MRN, atypical adenomatous hyperplasia, atypical MRN
Definitions
•
Dysplasia: Abnormal histologic growth that does not fulfill criteria of malignancy
Dysplastic focus: Cluster of dysplastic hepatocytes < 1 cm in diameter
Dysplastic nodule: Cluster of dysplastic hepatocytes > 1 cm in diameter
•
LRN: > 1 cm, usually seen in cirrhosis
No reliable gross or histologic criteria to distinguish RN and LGDN
–
LGDN is clonal proliferation; likelihood of progression to carcinoma is unclear
Most RN are probably not preneoplastic
•
HGDN: Nodule with atypical cytologic and architectural features believed to be precursor of carcinoma
•
Large cell change (formerly large cell dysplasia)
Large hepatocytes with nuclear enlargement, hyperchromasia, prominent nucleoli, often multinucleated
–
Abundant cytoplasm, normal nuclear:cytoplasmic ratio
Very common in cirrhotic liver
Formerly thought to be precursor of hepatocellular carcinoma (HCC)
–
No longer considered preneoplastic but rather regenerative or degenerative phenomenon
–
Low proliferation rate and absence of
p 53 mutations also do not support preneoplastic process
•
Small cell change (formerly small cell dysplasia)
Small hepatocytes with increased nuclear:cytoplasmic ratio and hyperchromatic nuclei
–
High proliferative activity and
p 53 overexpression can occur
Likely to be preneoplastic when occurring in expansile nodules
Poorly defined or diffuse areas of small cell change without nodular configuration may represent regenerative phenomenon
Small cell regenerative foci common in biliary disease, unlikely to be preneoplastic
CLINICAL ISSUES
Presentation
•
Occur in setting of cirrhosis, usually in background of hepatitis B, hepatitis C, alcoholic liver disease, hemochromatosis
Uncommon in chronic biliary diseases
Occasionally in chronic liver disease without fully developed cirrhosis
Can occur in noncirrhotic liver in Budd-Chiari syndrome, portal vein thrombosis, or regeneration after necrosis
•
May be detected at autopsy, transplantation or by imaging
•
Serum AFP is normal or mildly elevated
Treatment
•
RN/LGDN: Follow-up by imaging and serological markers
•
HGDN: No well-defined guidelines; often ablated